Literature DB >> 24977456

Behavioral weight loss for the management of menopausal hot flashes: a pilot study.

Rebecca C Thurston1, Linda J Ewing, Carissa A Low, Aimee J Christie, Michele D Levine.   

Abstract

OBJECTIVE: Although adiposity has been considered to be protective against hot flashes, newer data suggest positive relationships between hot flashes and adiposity. No studies have been specifically designed to test whether weight loss reduces hot flashes. This pilot study aimed to evaluate the feasibility, acceptability, and initial efficacy of behavioral weight loss in reducing hot flashes.
METHODS: Forty overweight or obese women with hot flashes (≥ 4 hot flashes/d) were randomized to either behavioral weight loss intervention or wait-list control. Hot flashes were assessed before and after intervention via physiologic monitoring, diary, and questionnaire. Comparisons of changes in hot flashes and anthropometrics between conditions were performed via Wilcoxon tests.
RESULTS: Study retention (83%) and intervention satisfaction (93.8%) were high. Most women (74.1%) reported that hot flash reduction was a major motivator for losing weight. Women randomized to the weight loss intervention lost more weight (-8.86 kg) than did women randomized to control (+0.23 kg; P < 0.0001). Women randomized to weight loss also showed greater reductions in questionnaire-reported hot flashes (2-wk hot flashes, -63.0) than did women in the control group (-28.0; P = 0.03)-a difference not demonstrated in other hot flash measures. Reductions in weight and hot flashes were significantly correlated (eg, r = 0.47, P = 0.006).
CONCLUSIONS: This pilot study shows a behavioral weight loss program that is feasible, acceptable, and effective in producing weight loss among overweight or obese women with hot flashes. Findings indicate the importance of a larger study designed to test behavioral weight loss for hot flash reduction. Hot flash management could motivate women to engage in this health-promoting behavior.

Entities:  

Mesh:

Year:  2015        PMID: 24977456      PMCID: PMC4270932          DOI: 10.1097/GME.0000000000000274

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  36 in total

1.  Feasibility and psychometrics of an ambulatory hot flash monitoring device.

Authors:  J S Carpenter; M A Andrykowski; R R Freedman; R Munn
Journal:  Menopause       Date:  1999       Impact factor: 2.953

Review 2.  Physiology of hot flashes.

Authors:  R R Freedman
Journal:  Am J Hum Biol       Date:  2001 Jul-Aug       Impact factor: 1.937

3.  International physical activity questionnaire: 12-country reliability and validity.

Authors:  Cora L Craig; Alison L Marshall; Michael Sjöström; Adrian E Bauman; Michael L Booth; Barbara E Ainsworth; Michael Pratt; Ulf Ekelund; Agneta Yngve; James F Sallis; Pekka Oja
Journal:  Med Sci Sports Exerc       Date:  2003-08       Impact factor: 5.411

4.  An alternative to Unibase/glycol as an effective nonhydrating electrolyte medium for the measurement of electrodermal activity.

Authors:  Sharon L Dormire; Janet S Carpenter
Journal:  Psychophysiology       Date:  2002-07       Impact factor: 4.016

Review 5.  Human morphology and temperature regulation.

Authors:  G S Anderson
Journal:  Int J Biometeorol       Date:  1999-11       Impact factor: 3.787

Review 6.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

7.  The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  1999-04       Impact factor: 19.112

8.  How well do different measurement modalities estimate the number of vasomotor symptoms? Findings from the Study of Women's Health Across the Nation FLASHES Study.

Authors:  Polly Fu; Karen A Matthews; Rebecca C Thurston
Journal:  Menopause       Date:  2014-02       Impact factor: 2.953

9.  Laboratory and ambulatory monitoring of menopausal hot flashes.

Authors:  R R Freedman
Journal:  Psychophysiology       Date:  1989-09       Impact factor: 4.016

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  8 in total

1.  Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).

Authors:  M Caprio; M Infante; E Moriconi; A Armani; A Fabbri; G Mantovani; S Mariani; C Lubrano; E Poggiogalle; S Migliaccio; L M Donini; S Basciani; A Cignarelli; E Conte; G Ceccarini; F Bogazzi; L Cimino; R A Condorelli; S La Vignera; A E Calogero; A Gambineri; L Vignozzi; F Prodam; G Aimaretti; G Linsalata; S Buralli; F Monzani; A Aversa; R Vettor; F Santini; P Vitti; L Gnessi; U Pagotto; F Giorgino; A Colao; A Lenzi
Journal:  J Endocrinol Invest       Date:  2019-05-20       Impact factor: 4.256

2.  Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women's Health Across the Nation (SWAN).

Authors:  Ellen B Gold; Sybil L Crawford; Janie F Shelton; Ping G Tepper; Carolyn J Crandall; Gail A Greendale; Karen A Matthews; Rebecca C Thurston; Nancy E Avis
Journal:  Menopause       Date:  2017-01       Impact factor: 2.953

Review 3.  Using menopausal hormone therapy after a cancer diagnosis in Ireland.

Authors:  Fionán Donohoe; Yvonne O'Meara; Aidin Roberts; Louise Comerford; Catherine M Kelly; Janice M Walshe; Deirdre Lundy; Martha Hickey; Donal J Brennan
Journal:  Ir J Med Sci       Date:  2022-02-09       Impact factor: 1.568

4.  Management of Obesity in Midlife Women-An AIIMS DST FOGSI Initiative.

Authors:  Geetha Balsarkar
Journal:  J Obstet Gynaecol India       Date:  2022-07-21

5.  Oncology Advanced Practitioners and Breast Cancer Prevention.

Authors:  Wendy H Vogel; Haley Pace; Matthew Brignola
Journal:  J Adv Pract Oncol       Date:  2020-11-01

6.  Metabolically healthy and unhealthy obesity and risk of vasomotor symptoms in premenopausal women: cross-sectional and cohort studies.

Authors:  Sunju Namgoung; Yoosoo Chang; Chae-Yeon Woo; Yejin Kim; Jeonggyu Kang; Ria Kwon; Ga-Young Lim; Hye Rin Choi; Kye-Hyun Kim; Hoon Kim; Yun Soo Hong; Di Zhao; Juhee Cho; Eliseo Guallar; Hyun-Young Park; Seungho Ryu
Journal:  BJOG       Date:  2022-06-07       Impact factor: 7.331

7.  A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study.

Authors:  Ekta Kapoor; Stephanie Faubion; Ryan T Hurt; Karen Fischer; Darrell Schroeder; Shawn Fokken; Ivana T Croghan
Journal:  Menopause       Date:  2020-11       Impact factor: 3.310

8.  Obesity associates with vasomotor symptoms in postmenopause but with physical symptoms in perimenopause: a cross-sectional study.

Authors:  Seul Koo; Younjhin Ahn; Joong-Yeon Lim; Juhee Cho; Hyun-Young Park
Journal:  BMC Womens Health       Date:  2017-12-08       Impact factor: 2.809

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.